These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 9504692)

  • 21. Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation.
    Copie-Bergman C; Niedobitek G; Mangham DC; Selves J; Baloch K; Diss TC; Knowles DN; Delsol G; Isaacson PG
    J Pathol; 1997 Nov; 183(3):287-92. PubMed ID: 9422983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
    Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
    Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
    Perera SM; Thomas JA; Burke M; Crawford DH
    J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Bar virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype.
    DiGiuseppe JA; Wu TC; Zehnbauer BA; McDowell PR; Barletta JM; Ambinder RF; Mann RB
    Mod Pathol; 1995 Jun; 8(5):553-9. PubMed ID: 7675777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant lymphoma of the adrenal gland: its possible correlation with the Epstein-Barr virus.
    Ohsawa M; Tomita Y; Hashimoto M; Yasunaga Y; Kanno H; Aozasa K
    Mod Pathol; 1996 May; 9(5):534-43. PubMed ID: 8733769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.
    Shiozawa E; Saito B; Yamochi-Onizuka T; Makino R; Takimoto M; Nakamaki T; Tomoyasu S; Ota H
    Pathol Int; 2007 Oct; 57(10):688-93. PubMed ID: 17803658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
    Itakura O; Kikuta H
    Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders.
    Iwatsuki K; Ohtsuka M; Harada H; Han G; Kaneko F
    Arch Dermatol; 1997 Sep; 133(9):1081-6. PubMed ID: 9301584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
    Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
    J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.